Anthony E. Sisk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anthony E. Sisk has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Steven S. Raman
David Geffen School of Medicine at UCLA
4 shared publications - Kyunghyun Sung
Department of Radiological Sciences, University of California, Los Angeles, CA 92521, USA
3 shared publications Robert E. Reiter
Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, Calif
3 shared publications- David S. K. Lu
Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine at UCLA , Los Angeles, CA 90025
2 shared publications - Holden Wu
Department of Radiological Sciences David Geffen School of Medicine, University of California Los Angeles Los Angeles California USA
2 shared publications - Sohrab Afshari Mirak
Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, USA
2 shared publications
Latest Publications
- 1 May 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (3) , e240336
Deep Learning-based Anatomy-Aware Morph Model for Registration of Prostate Whole-Mount Histopathology to MRI
A novel deep learning–based method for intrapatient multimodal image registration was developed that achieved high performance in aligning prostate MR and whole-mount histopathology images, facilitating accurate prostate cancer mapping.
- 1 May 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (3) , e240336
Deep Learning-based Anatomy-Aware Morph Model for Registration of Prostate Whole-Mount Histopathology to MRI
A novel deep learning–based method for intrapatient multimodal image registration was developed that achieved high performance in aligning prostate MR and whole-mount histopathology images, facilitating accurate prostate cancer mapping.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Heterogeneous Presentations of iMCD: A Single‐Institution Case Series
Background: Idiopathic multicentric Castleman disease (iMCD) is a rare lymphadenopathic disorder characterized by hyperplasia of multiple lymph nodes and can be associated with a wide range of symptoms and presentations, from mild disease to life‐threatening organ failure. Varied histopathological features and heterogeneous presentation of this rare entity can make the diagnosis quite challenging for both hematologists and other specialists who may encounter patients at various stages of disease progression. Method: We analyze five different clinical presentations at our institution to demonstrate challenging routes of diagnosis and treatment complexities of iMCD. We aim to raise awareness to the importance of early diagnosis and appropriate management of this rare condition. Results: All patients in this series presented with symptomatic lymphadenopathy. We highlight one rare instance of thrombocytopenia, anasarca/ascites, fever, reticulin fibrosis or renal dysfunction, and organomegaly (TAFRO) syndrome with elusive iMCD, which illustrates the challenges in the diagnosis of this rare condition and the importance of early recognition of its symptoms to avoid decompensation of patients. We also review established treatment guidelines and response criteria to siltuximab as outlined in the international consensus treatment guidelines. Conclusion: These cases highlight the heterogeneity and challenging diagnosis of this rare cytokine‐driven hematological disorder and the role of siltuximab in the treatment of iMCD.
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Open AccessHeterogeneous Presentations of iMCD: A Single‐Institution Case Series
Background: Idiopathic multicentric Castleman disease (iMCD) is a rare lymphadenopathic disorder characterized by hyperplasia of multiple lymph nodes and can be associated with a wide range of symptoms and presentations, from mild disease to life‐threatening organ failure. Varied histopathological features and heterogeneous presentation of this rare entity can make the diagnosis quite challenging for both hematologists and other specialists who may encounter patients at various stages of disease progression. Method: We analyze five different clinical presentations at our institution to demonstrate challenging routes of diagnosis and treatment complexities of iMCD. We aim to raise awareness to the importance of early diagnosis and appropriate management of this rare condition. Results: All patients in this series presented with symptomatic lymphadenopathy. We highlight one rare instance of thrombocytopenia, anasarca/ascites, fever, reticulin fibrosis or renal dysfunction, and organomegaly (TAFRO) syndrome with elusive iMCD, which illustrates the challenges in the diagnosis of this rare condition and the importance of early recognition of its symptoms to avoid decompensation of patients. We also review established treatment guidelines and response criteria to siltuximab as outlined in the international consensus treatment guidelines. Conclusion: These cases highlight the heterogeneity and challenging diagnosis of this rare cytokine‐driven hematological disorder and the role of siltuximab in the treatment of iMCD.
- 1 January 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (1) , e240011
Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer
Quantitative 3-T multiparametric MRI parameters correlated with and helped predict the presence of aggressive large cribriform pattern and intraductal carcinoma prostate cancer at whole-mount histopathology.
- 1 January 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (1) , e240011
Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer
Quantitative 3-T multiparametric MRI parameters correlated with and helped predict the presence of aggressive large cribriform pattern and intraductal carcinoma prostate cancer at whole-mount histopathology.
- 22 October 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (24) , 40159-40169
From Simulation to Surgery: Comprehensive Validation of an Optical Sensor for Monitoring Focal Laser Ablation of Solid Organ Tumors
Solid organ tumors can be treated using focal laser ablation (FLA), in which a needle housing a laser fiber is inserted into a tumor and oncologic control is achieved through thermally induced tissue coagulation. The key advantage of this procedure over conventional approaches is that it has few side effects due to its minimally invasive nature. However, the lack of an inexpensive and accurate monitoring modality hinders widespread adoption. To address this unmet need, we have developed an optical probe capable of accurately monitoring the ablation procedure in real time, thus ensuring complete coagulation of the cancerous tissue. This is achieved by placing the probe at the desired ablation boundary and interrogating laser–tissue interaction in real time to detect the onset and propagation of the coagulation boundary. Here, we validate this novel monitoring modality through in silico, ex vivo, and in vivo studies. Monte Carlo simulation is performed to demonstrate the utility of the probe in a range of tissues including the prostate, liver, and brain. In all cases, the virtual optical probe is capable of detecting the coagulation boundary without any tissue-specific calibration. Next, an ex vivo bovine liver study is presented, in which laser ablation under optical probe monitoring is shown to be capable of creating ablation zones with a radial accuracy better than 1 mm. Finally, case studies from the first clinical trial of this technology are presented showing the successful adoption of this technique for monitoring laser ablation of prostate cancer.
- 22 October 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (24) , 40159-40169
From Simulation to Surgery: Comprehensive Validation of an Optical Sensor for Monitoring Focal Laser Ablation of Solid Organ Tumors
Solid organ tumors can be treated using focal laser ablation (FLA), in which a needle housing a laser fiber is inserted into a tumor and oncologic control is achieved through thermally induced tissue coagulation. The key advantage of this procedure over conventional approaches is that it has few side effects due to its minimally invasive nature. However, the lack of an inexpensive and accurate monitoring modality hinders widespread adoption. To address this unmet need, we have developed an optical probe capable of accurately monitoring the ablation procedure in real time, thus ensuring complete coagulation of the cancerous tissue. This is achieved by placing the probe at the desired ablation boundary and interrogating laser–tissue interaction in real time to detect the onset and propagation of the coagulation boundary. Here, we validate this novel monitoring modality through in silico, ex vivo, and in vivo studies. Monte Carlo simulation is performed to demonstrate the utility of the probe in a range of tissues including the prostate, liver, and brain. In all cases, the virtual optical probe is capable of detecting the coagulation boundary without any tissue-specific calibration. Next, an ex vivo bovine liver study is presented, in which laser ablation under optical probe monitoring is shown to be capable of creating ablation zones with a radial accuracy better than 1 mm. Finally, case studies from the first clinical trial of this technology are presented showing the successful adoption of this technique for monitoring laser ablation of prostate cancer.
- Open Access
- 30 July 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (31) , eabg7073
Regulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A)
Down-regulation of HMBOX1 via METTL3-catalyzed m 6 A causes genomic instability driven by telomere dysfunction in cancer.
- 30 July 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (31) , eabg7073
Open AccessRegulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A)
Down-regulation of HMBOX1 via METTL3-catalyzed m 6 A causes genomic instability driven by telomere dysfunction in cancer.
- 27 June 2021
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4) , e13656
Intestinal mucormycosis initially identified by next‐generation sequencing of cell‐free DNA
Mucormycosis is a rare fungal infection that typically affects severely immunocompromised individuals, often resulting in significant morbidity and mortality. Although early and aggressive intervention is necessary to prevent poor outcomes, diagnosis of this infection remains difficult. We report the first case, to our knowledge, of invasive gastrointestinal mucormycosis initially identified by next‐generation sequencing of cfDNA from the blood, and discuss the various benefits and challenges which come with new molecular diagnostic techniques.
- 27 June 2021
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4) , e13656
Intestinal mucormycosis initially identified by next‐generation sequencing of cell‐free DNA
Mucormycosis is a rare fungal infection that typically affects severely immunocompromised individuals, often resulting in significant morbidity and mortality. Although early and aggressive intervention is necessary to prevent poor outcomes, diagnosis of this infection remains difficult. We report the first case, to our knowledge, of invasive gastrointestinal mucormycosis initially identified by next‐generation sequencing of cfDNA from the blood, and discuss the various benefits and challenges which come with new molecular diagnostic techniques.
- 1 August 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (2) , 348-355
Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology
Diffusion-relaxation correlation spectrum imaging (DR CSI) parameters correlate with histopathologic microscopic prostate tissue compartments—epithelium, stroma, and lumen—in men with prostate cancer. Background Microstructural MRI has the potential to improve diagnosis and characterization of prostate cancer (PCa), but validation with histopathology is lacking. Purpose To validate ex vivo diffu...
- 1 August 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (2) , 348-355
Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology
Diffusion-relaxation correlation spectrum imaging (DR CSI) parameters correlate with histopathologic microscopic prostate tissue compartments—epithelium, stroma, and lumen—in men with prostate cancer. Background Microstructural MRI has the potential to improve diagnosis and characterization of prostate cancer (PCa), but validation with histopathology is lacking. Purpose To validate ex vivo diffu...
- 7 March 2019
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (6) , 2308-2315
The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas
Purpose To evaluate the effect of size and central location of the tumor on safety and efficacy of percutaneous CEUS- and CT-guided MWA in biopsy-proven renal cell carcinomas (RCCs). Materials and methods In this IRB-approved retrospective study, 69 biopsy-proven renal tumors in 56 patients, who underwent MWA in our institution from January 2013 to March 2017, were evaluated. Data collection included demographics, tumor characteristics, procedural protocols, and follow-up visits within 6 months post procedure. Primary outcomes were assessed by technical success (TS), local tumor progression (LTP), and complications. The Kaplan–Meier analysis was used for survival rate. Results Overall technical success was achieved for all 69 lesions (92.8% primary TS, 100% overall). Median nephrometry score was 8 (4–11) and median tumor size was 2.5 cm (0.8–7). Five lesions which required second ablation had significantly higher median tumor size 4 cm (P = 0.039) with the same nephrometry score. Renal function remained stable with no significant change in eGFR before or after ablation. The LTP rate was 5.8%. The most recurrent tumors were clear cell (50%) followed by papillary tumors (25%). The complication rate was 5.8% with minor complications (hematoma and pain) and no major issues. There was no significant association between nephrometry score and technical success, recurrence, or complication rates. Overall and tumor-specific survival rates were 96.7% and 100% at 11.9 months. Conclusions Image-guided MWA appears to be a safe and effective treatment regardless of nephrometry score and tumor location with high technical success, low recurrence, and complication rates.
- 7 March 2019
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (6) , 2308-2315
The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas
Purpose To evaluate the effect of size and central location of the tumor on safety and efficacy of percutaneous CEUS- and CT-guided MWA in biopsy-proven renal cell carcinomas (RCCs). Materials and methods In this IRB-approved retrospective study, 69 biopsy-proven renal tumors in 56 patients, who underwent MWA in our institution from January 2013 to March 2017, were evaluated. Data collection included demographics, tumor characteristics, procedural protocols, and follow-up visits within 6 months post procedure. Primary outcomes were assessed by technical success (TS), local tumor progression (LTP), and complications. The Kaplan–Meier analysis was used for survival rate. Results Overall technical success was achieved for all 69 lesions (92.8% primary TS, 100% overall). Median nephrometry score was 8 (4–11) and median tumor size was 2.5 cm (0.8–7). Five lesions which required second ablation had significantly higher median tumor size 4 cm (P = 0.039) with the same nephrometry score. Renal function remained stable with no significant change in eGFR before or after ablation. The LTP rate was 5.8%. The most recurrent tumors were clear cell (50%) followed by papillary tumors (25%). The complication rate was 5.8% with minor complications (hematoma and pain) and no major issues. There was no significant association between nephrometry score and technical success, recurrence, or complication rates. Overall and tumor-specific survival rates were 96.7% and 100% at 11.9 months. Conclusions Image-guided MWA appears to be a safe and effective treatment regardless of nephrometry score and tumor location with high technical success, low recurrence, and complication rates.
- 14 January 2017
- Published by Springer Nature in Endocrine Pathology
- Vol. 28 (2) , 152-158
Adrenal Teratoma: a Case Series and Review of the Literature
Adrenal teratomas are rare neoplasms and there is limited data on their surgical outcomes and long-term prognosis. We aimed to review our institutional experience and compare this to the existing literature on adrenal teratomas in adults and children. An institutional pathology database was searched for cases of adrenal teratoma (June 1956–July 2016). Clinical and imaging data were abstracted from the medical records and pathology slides were obtained for review. In addition, a PubMed search for “adrenal teratoma” from June 1952 to July 2016 was performed to identify reports of primary adrenal teratoma in patients of all ages. Of 7706 patients who underwent adrenalectomy during the study period at our institution, three patients were identified with adrenal teratoma. Patients were 24, 26, and 29 years of age, respectively. Two patients presented with abdominal pain and two of the three underwent a laparoscopic adrenalectomy. A pathologic examination revealed mature cystic teratomas that frequently displayed well-differentiated respiratory, digestive, and squamous epithelia. Eighteen case reports in the literature were identified in patients 17–61 years of age. Patients presented most frequently with abdominal or flank pain (63.6%). Median tumor diameter was 9.0 cm and tumors were frequently left-sided (81.8%), cystic (63.6%), and calcified (72.7%) on either radiologic or pathologic examination. Primary adrenal teratomas are rare neoplasms that typically present as large, left-sided nodules with cystic and calcified components seen radiographically. Although the data are limited, they are generally amenable to laparoscopic resection and have a very favorable prognosis.
- 14 January 2017
- Published by Springer Nature in Endocrine Pathology
- Vol. 28 (2) , 152-158
Adrenal Teratoma: a Case Series and Review of the Literature
Adrenal teratomas are rare neoplasms and there is limited data on their surgical outcomes and long-term prognosis. We aimed to review our institutional experience and compare this to the existing literature on adrenal teratomas in adults and children. An institutional pathology database was searched for cases of adrenal teratoma (June 1956–July 2016). Clinical and imaging data were abstracted from the medical records and pathology slides were obtained for review. In addition, a PubMed search for “adrenal teratoma” from June 1952 to July 2016 was performed to identify reports of primary adrenal teratoma in patients of all ages. Of 7706 patients who underwent adrenalectomy during the study period at our institution, three patients were identified with adrenal teratoma. Patients were 24, 26, and 29 years of age, respectively. Two patients presented with abdominal pain and two of the three underwent a laparoscopic adrenalectomy. A pathologic examination revealed mature cystic teratomas that frequently displayed well-differentiated respiratory, digestive, and squamous epithelia. Eighteen case reports in the literature were identified in patients 17–61 years of age. Patients presented most frequently with abdominal or flank pain (63.6%). Median tumor diameter was 9.0 cm and tumors were frequently left-sided (81.8%), cystic (63.6%), and calcified (72.7%) on either radiologic or pathologic examination. Primary adrenal teratomas are rare neoplasms that typically present as large, left-sided nodules with cystic and calcified components seen radiographically. Although the data are limited, they are generally amenable to laparoscopic resection and have a very favorable prognosis.